Skip to main content
OpenTrials
Completed

NCT Number: NCT04427670

Group Intervention Study for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan

Dysarthria is a common problem in Pakistan. therefore the current study aims to translate the dysarthria communication tools into urdu language for better understanding the population and the problem

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dysarthria As Late Effect of Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Stroke Vascular Diseases

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sheikh Zayed medical Complex

Lahore, Punjab Province, 54000, Pakistan

About this study

Dysarthria is the inefficiency or restricted capability to form intelligible speech because of the inability of motor control on the speech structures. There are many therapeutic approaches in Pakistan that are in use for the patients with dysarthria following stroke. One of them is one to one intervention which may include one dysarthria client along with the speech therapist. The therapist delivers step by step instructions to the client. The essential assessments are being held to initiate the treatment. The application of this intervention approach leaves some drawbacks, such as, the patients find it difficult to relate and adapt to the treatment offered. Generalization also seems to be complicated. The patients express a lack in motivation and support. The other mode of approach is group intervention, in which multiple dysarthria clients along with their caregivers & speech therapist are included. In the later one, there are greater chances of recovery for patients as they get peer support and build confidence through newfound friends, peer communication with realistic social setting, learning through teaching, increased awareness of skills and it is time constraints. The culture of practicing group sessions with dysarthria patients is lacked in Pakistan, which intends to meet and compensate for all the drawbacks and lacks of one on one intervention. By including the Dysarthria patients, therapist and the caregivers in the group intervention, there're greater chances of reduced anxiety for both patients & caregivers regarding disorder & its recovery.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 40 to 70 years age ranges
  • History of dysarthria previous six monthes
  • Primary level of education
  • Functional hearing and visual ablities -

Exclusion criteria

  • Patient with age below 40 to 70
  • Patients with diagnosis severe psychological illness
  • Patient with developmental dysarthria
  • Patient who come alone without any attendent

Treatment and study plan

Group Intervention

Other

Group intervention programme designed for stroke survivors with dysarthria and their carers. The programme was eight weeks long, with weekly two sessions, each session lasting for two hours, lead by speech language therapist and was comprised of activities which addressed participants education about their dysarthria and stroke. The role of family , peer and professional was to provide support and communication practice.

Regular speech therapy

Other

Regular speech therapy will be provided to the controlled group.Regular speech therapy is one to one speech therapy session,conducted twice a week for the duration of eight weeks.This intervention is implemented to patients with dysarthria following stroke in a format of one patient and one therapist per session.

Primary outcomes

  1. efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Roberston Dysarthria Profile.

    Time frame: 6 months

    Roberston Dysarthria Profile take responses on 5 point likert scale where 1 for worst and 5 for better outcome.

  2. efficacy of group intervention for Patients With Dysarthria will be assessed by translated version of Communication Effectivness Measure

    Time frame: 6 months

    Communication Effectivness Measure is seven point scale arranging from 1 to 7 where 1 for worst outcome and 7 for better outcome.

  3. Efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Communicative Participation Item Bank.

    Time frame: 6 months

    Communicative Participation Item Bank is four point scale arranging from 0 to 3 where 0 for better communication participation and 3 for worst communication participation.

  4. Efficacy of group intervention for Patients With Dysarthria will be assessed by Gernal Health Questionnaire

    Time frame: 6 months

    Gernal Health Questionnaire is four point scale in which responses 1 means better and 4 for worst condition

  5. Efficacy of group intervention for Patients With Dysarthria will be assessed by Speech Intelligiblity Test

    Time frame: 6 months

    Speech Intelligiblity Test is three point scale where 2 stands for correct utterances and 0 shows wrong production of sounds.

Sponsors and collaborators

Lead sponsor

Isra University

Other

Registry information

Official study title

Implementation and Feasibility Study of Group Intervention for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan

Important dates

Study start
2020
Primary completion
2021
Study completion
2024
First posted
Jun 11, 2020
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.